Mylan N.V.:戦略・SWOT・企業財務分析

◆英語タイトル:Mylan N.V. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015457
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Mylan N.V. – Strategy, SWOT and Corporate Finance Report
Summary

Mylan N.V. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Mylan N.V. (Mylan or ‘the company’) is a leading provider of generic pharmaceutical products. It also develops, licenses, manufactures, markets and distributes branded generic and specialty pharmaceuticals. The company primarily operates in North America and Europe. It is headquartered in Canonsburg, Pennsylvania.

Scope

- Detailed information on Mylan N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Mylan N.V. in the form of a SWOT analysis
- An in-depth view of the business model of Mylan N.V. including a breakdown and examination of key business segments
- Intelligence on Mylan N.V.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Mylan N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Mylan N.V. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Mylan N.V. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Mylan N.V.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Mylan N.V.: Company Overview
Mylan N.V.: Overview and Key Facts
Mylan N.V.: Overview
Mylan N.V.: Key Facts
Mylan N.V.: Key Employees
Mylan N.V.: Key Employee Biographies
Mylan N.V.: Major Products and Services
Mylan N.V.: Company History
Mylan N.V.: Management Statement
Mylan N.V.: Locations and Subsidiaries
Mylan N.V.: Key Competitors
Mylan N.V.: Company Analysis
Mylan N.V.: Business Description
Mylan N.V.: SWOT Analysis
Mylan N.V.: SWOT Overview
Mylan N.V.: Strengths
Mylan N.V.: Weaknesses
Mylan N.V.: Opportunities
Mylan N.V.: Threats
Mylan N.V.: Corporate Financial Deals Activity
Mylan N.V.: Financial Deals Overview
Mylan N.V.: Targets and Partners
Mylan N.V.: Top Deals 2013 – 2017YTD*
Mylan N.V.: Advisors
Mylan N.V.: Top Legal Advisors
Mylan N.V.: Top Financial Advisors
Mylan N.V.: Mergers and Acquisitions
Mylan N.V.: Corporate Venturing
Mylan N.V.: Capital Raising
Mylan N.V.: Partnership
Mylan N.V.: Recent Developments
Mylan N.V.: News and Events Summary
Mylan N.V.: Business Expansion
Mylan N.V.: Corporate Governance
Mylan N.V.: Financial Performance
Mylan N.V.: Red Flags/DistressSignals
Mylan N.V.: Research & Development
Mylan N.V.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Mylan N.V.: Key Facts
Table 2: Mylan N.V.: Key Employees
Table 3: Mylan N.V.: Locations and Subsidiaries
Table 4: Mylan N.V.: Key Competitors
Table 5: Mylan N.V.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Mylan N.V.: M&A Average Deal Size - Value (US$m)
Table 7: Mylan N.V.: Targets and Partners
Table 8: Mylan N.V.: Top Deals 2013 - 2017YTD*
Table 9: Mylan N.V.: Legal Advisor Ranking by Value (US$m)
Table 10: Mylan N.V.: Financial Advisor Ranking by Value (US$m)
Table 11: Mylan N.V.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 12: Mylan N.V.: M&A Activity by Geography (2013 - YTD*2017)
Table 13: Mylan N.V.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 14: Mylan N.V.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 15: Mylan N.V.: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 16: Mylan N.V.: Capital Raising by Deal Type (2013 - YTD*2017)
Table 17: Mylan N.V.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 18: Mylan N.V.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 19: Mylan N.V.: News and Events Summary
Table 20: Mylan N.V.: Business Expansion
Table 21: Mylan N.V.: Corporate Governance
Table 22: Mylan N.V.: Financial Performance
Table 23: Mylan N.V.: Red Flags/DistressSignals
Table 24: Mylan N.V.: Research & Development
Table 25: Mylan N.V.: Strategy and Operations

★海外企業調査レポート[Mylan N.V.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kineta Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • PerkinElmer Inc (PKI):医療機器:M&Aディール及び事業提携情報
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company’s major products include cytogenetics reagen …
  • YGM Trading Ltd.:企業の戦略・SWOT・財務情報
    YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Carbonite Inc (CARB):企業の財務・戦略的SWOT分析
    Summary Carbonite Inc (Carbonite) is a subsidiary of Open Text Corporation, is a software development company that provides cloud and hybrid backup products and solutions. The company provides automatic backup solutions for home including personal basic, personal prime, and personal plus, among othe …
  • Bon Secours Health System Inc:企業の戦略的SWOT分析
    Bon Secours Health System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Total E&P USA Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Total E&P USA Inc (TEP USA) formerly Elf Exploration Inc, a subsidiary of Total S.A., is an energy service providing company that explores and produces crude oil and natural gas. The company offers offshore oil production and exploration in the Gulf of Mexico to onshore unconventional shale …
  • Essilor International Compagnie Generale d’Optique SA (EI):企業の財務・戦略的SWOT分析
    Essilor International Compagnie Generale d'Optique SA (EI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compa …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Senzime AB (SEZI):企業の財務・戦略的SWOT分析
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • Diversicare Healthcare Services Inc (DVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary Diversicare Healthcare Services Inc (Diversicare), formerly Advocat Inc is a healthcare service provider that offers post acute care services and short term rehabilitation and long-term care services to nursing home patients. The company’s services include life steps rehabilitation program, …
  • Randox Laboratories Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Randox Laboratories Ltd (Randox) is a clinical diagnostic company that manufactures and provides clinical diagnostic solutions to laboratories. The company’s products include biochip analyzers, biochip immunoassays, clinical chemistry analyzers and diagnostic reagents among others. It offers …
  • Idaho Power Co:電力:M&Aディール及び事業提携情報
    Summary Idaho Power Company (Idaho Power), a subsidiary of IDACORP, Inc., is an electric utility that carries out the generation, purchase, transmission, distribution and sale of electric energy. Idaho Power is regulated by the Federal Energy Regulatory Commission (FERC), as well as state regulatory …
  • Biocon Ltd (BIOCON):企業の財務・戦略的SWOT分析
    Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • E.ON SE (EOAN)-石油・ガス分野:企業M&A・提携分析
    Summary E.ON SE (E.ON), formerly E.ON AG, is an energy company that generates electricity, produces, stores, transports, and supplies gas and conducts trading, carbon sourcing, and electricity and gas distribution. It generates power from diverse fuel sources including wind, hydro, nuclear, coal, na …
  • GamaMabs Pharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary GamaMabs Pharma SA (GamaMabs) is a clinical-stage immuno-oncology company that develops optimized therapeutic antibodies for the treatment of cancer. The company’s lead product candidate GM102, is an anti-AMHR2, Emabling engineered humanized mAb product targeting the receptor of anti-Mulleri …
  • Porcelanosa Grupo AIE:企業の戦略・SWOT・財務情報
    Porcelanosa Grupo AIE - Strategy, SWOT and Corporate Finance Report Summary Porcelanosa Grupo AIE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Proteome Sciences Plc (PRM):企業の財務・戦略的SWOT分析
    Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • C&A:企業の戦略・SWOT・財務情報
    C&A - Strategy, SWOT and Corporate Finance Report Summary C&A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing …
  • Taiho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group focuses on the development, production and marketing of pharmaceutical products in the fields of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic age …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆